Loading company…
Matter Neuroscience develops tools and treatments related to brain health and neurological disorders.
Founded in 2019 and based in Colorado, Matter Neuroscience develops treatments for neurological disorders and provides information about brain chemistry. Its app uses molecular-level insights on dopamine, oxytocin and cannabinoids to help users reflect on experiences and neurotransmitter activity. In February 2024, it raised USD 26 million led by Exor Ventures and ARCH Venture Partners, with Polaris Partners and Collaborative Fund participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in